Modified pegRNAs mitigate scaffold-derived prime editing by-products

Prime editors (PEs) employ reverse transcriptase (RT) to install genomic edits using a template within the prime editing guide RNA (pegRNA). RT creates a 3' genomic flap containing the intended edit. However, reverse transcription can continue beyond the template, incorporating the pegRNA scaffold sequence into the 3' flap. These scaffold-derived by-products can be installed alongside the intended edit, reducing prime editing precision. Here, we develop a method that prevents RT from accessing the scaffold, thereby mitigating such by-products. We demonstrate that an internal abasic spacer or 2'-O-methylation within the pegRNAs terminates RT at the end of the template. This prevents scaffold-derived sequences from being incorporated into the target locus. We benchmark these pegRNAs in different cell types and demonstrate that they can be used with processive PEs such as PE6d or PE**. Our findings provide a simple approach to mitigate a common prime editing by-product and improve prime editing precision.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-04-09
DOI
https://doi.org/10.1038/s41467-025-58653-1
Citations
6
Primary Topic
CRISPR and Genetic Engineering
Type
article
Field-Weighted Citation Impact
4.84

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Modified pegRNAs mitigate scaffold-derived prime editing by-products

Euan Gordon, Pei-Pei Hsieh, Nina Akrap, Louis Dacquay et al.
6 citations
Nature Communications
CRISPR and Genetic Engineering
4.84
article

Modified pegRNAs mitigate scaffold-derived prime editing by-products

Euan Gordon, Pei-Pei Hsieh, Nina Akrap, Louis Dacquay, Marcello Maresca, George Thom, Saša Šviković, Anna Shiriaeva, Katja Madeyski-Bengtson, Mike Firth, Panagiotis Antoniou, Anna-Lena Loyd, Martin Peterka, Hanna Mårtensson, Salman Mustfa
article en
6 citations

Abstract

Prime editors (PEs) employ reverse transcriptase (RT) to install genomic edits using a template within the prime editing guide RNA (pegRNA). RT creates a 3' genomic flap containing the intended edit. However, reverse transcription can continue beyond the template, incorporating the pegRNA scaffold sequence into the 3' flap. These scaffold-derived by-products can be installed alongside the intended edit, reducing prime editing precision. Here, we develop a method that prevents RT from accessing the scaffold, thereby mitigating such by-products. We demonstrate that an internal abasic spacer or 2'-O-methylation within the pegRNAs terminates RT at the end of the template. This prevents scaffold-derived sequences from being incorporated into the target locus. We benchmark these pegRNAs in different cell types and demonstrate that they can be used with processive PEs such as PE6d or PE**. Our findings provide a simple approach to mitigate a common prime editing by-product and improve prime editing precision.

Nature CommunicationsVol. 16(1)
AstraZeneca (United Kingdom) (GB), Promega (United States) (US), AstraZeneca (Singapore) (SG), AstraZeneca (Finland) (FI), AstraZeneca (Sweden) (SE), AstraZeneca (Germany) (DE)
AstraZeneca, European Commission, HORIZON EUROPE Framework Programme
Openalex Percentile: Top 5%
CRISPR and Genetic Engineering
4.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.